These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 11480493

  • 21. [Use of bisphosphates in treatment of primary and secondary osteoporosis].
    Olszyński WP.
    Pol Tyg Lek; 1995 Nov; 50(44-47):56-8. PubMed ID: 8643431
    [Abstract] [Full Text] [Related]

  • 22. [Steroid induced osteoporosis: prevention and treatment].
    Roux C, Orcel P.
    Rev Med Interne; 2003 Jun; 24(6):384-8. PubMed ID: 12814827
    [Abstract] [Full Text] [Related]

  • 23. Corticosteroid-induced osteoporosis.
    Adachi JD, Bensen WG, Cividino A.
    J Am Med Womens Assoc (1972); 1998 Jun; 53(1):25-30, 40. PubMed ID: 9458622
    [Abstract] [Full Text] [Related]

  • 24. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
    Gennari C, Nuti R, Agnusdei D, Camporeale A, Martini G.
    Drug Saf; 1994 Sep; 11(3):179-95. PubMed ID: 7811400
    [Abstract] [Full Text] [Related]

  • 25. Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Clin Invest; 1998 Oct 15; 102(8):1627-33. PubMed ID: 9788977
    [Abstract] [Full Text] [Related]

  • 26. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM, Carson DS, Barrington R.
    J Fam Pract; 2000 Sep 15; 49(9):839-48. PubMed ID: 11032210
    [Abstract] [Full Text] [Related]

  • 27. [Post-steroidal osteoporosis].
    Drozdzowska B, Pluskiewicz W.
    Przegl Lek; 1999 Sep 15; 56(2):157-60. PubMed ID: 10375951
    [Abstract] [Full Text] [Related]

  • 28. [Corticosteroid-induced osteoporosis].
    Briot K, Roux C.
    Rev Med Interne; 2013 May 15; 34(5):315-23. PubMed ID: 23238181
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Osteoporosis. Methods to prevent fractures in patients at high risk.
    Watts NB.
    Postgrad Med; 1994 Apr 15; 95(5):73-4, 77-9, 83-8. PubMed ID: 8153049
    [Abstract] [Full Text] [Related]

  • 31. The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression.
    Amin S, Lavalley MP, Simms RW, Felson DT.
    J Bone Miner Res; 2002 Aug 15; 17(8):1512-26. PubMed ID: 12162505
    [Abstract] [Full Text] [Related]

  • 32. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
    Kapetanakis EI, Antonopoulos AS, Antoniou TA, Theodoraki KA, Zarkalis DA, Sfirakis PD, Chilidou DA, Alivizatos PA.
    J Heart Lung Transplant; 2005 May 15; 24(5):526-32. PubMed ID: 15896748
    [Abstract] [Full Text] [Related]

  • 33. Management of corticosteroid-induced osteoporosis.
    Drug Ther Bull; 2010 Sep 15; 48(9):98-101. PubMed ID: 20810708
    [Abstract] [Full Text] [Related]

  • 34. [Cortisone-induced osteoporosis: from physiopathology to treatment].
    Audran M, Basle MF.
    Rev Med Interne; 1991 Sep 15; 12(6):458-9, 461-4. PubMed ID: 1792440
    [Abstract] [Full Text] [Related]

  • 35. Corticosteroid osteoporosis.
    Sambrook PN.
    Z Rheumatol; 2000 Sep 15; 59 Suppl 1():45-7. PubMed ID: 10769436
    [Abstract] [Full Text] [Related]

  • 36. Steroid-induced osteoporosis.
    Sambrook PN.
    Ann Acad Med Singap; 2002 Jan 15; 31(1):48-53. PubMed ID: 11885496
    [Abstract] [Full Text] [Related]

  • 37. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S, Rossini M.
    Wien Med Wochenschr; 1993 Jan 15; 143(14-15):395-7. PubMed ID: 8256456
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
    Richy F, Ethgen O, Bruyere O, Reginster JY.
    Osteoporos Int; 2004 Apr 15; 15(4):301-10. PubMed ID: 14740153
    [Abstract] [Full Text] [Related]

  • 39. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.
    Cremers S, Garnero P.
    Drugs; 2006 Apr 15; 66(16):2031-58. PubMed ID: 17112299
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.